Search

everythinglearnresearchcommunity

for

Search:↓

More research needed to confirm finasteride as standard treatment for FFA.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

The fer-ts mutation in plants prevents root hair growth at high temperatures.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

A patient with hair loss condition grew excessive hair in areas covered by a cast.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Formalin-induced pain increases testosterone breakdown in the rat brain and spinal cord.

FLRG and follistatin have different roles in wound healing.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The skin-responsive device improved beard and body hair transplant success and increased surgeons' willingness to perform the procedure.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Follicular unit transplantation treats hair loss and restores eyebrows with short recovery and natural results.

FFA in young women is often missed, and no single treatment works best.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Hair restoration surgeons must understand the differences between CTE and FPHL for accurate diagnosis and treatment.

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

The document concludes that follicular unit transplantation offers more natural results and better graft survival than older hair transplant methods.

Botox injections may be a safe and effective way to treat severe, itchy skin disease when other treatments fail.

Trichoscopic features can help dermatologists distinguish between female pattern hair loss and chronic telogen effluvium.

Early diagnosis and quick treatment improve life quality for FFA patients.

Testosterone plus finasteride increases bone density in men with spinal cord injuries.

A girl with a rare genetic disorder had a unique bone condition, highlighting the need for careful diagnosis and suggesting the disorder might be more common than thought.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Eyebrow hair transplants in patients with frontal fibrosing alopecia may look good at first but often lose the new hair after a few years.

Testosterone and finasteride improve body composition in men with spinal cord injury.